HLUN.US HEALTHeUNIVERSE Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 14, 2026
Market cap
USD 11.8K
P/E
0.1x
P/B
-
ROE
3.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2006.

Is HLUN.US undervalued?

Graham number

The Graham number of HEALTHeUNIVERSE Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HEALTHeUNIVERSE Inc fundamental analysis

No fundamental analysis for HEALTHeUNIVERSE Inc yet.

HEALTHeUNIVERSE Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HEALTHeUNIVERSE Inc

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various business…

Full company profile